Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Rhodes Jason P Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Rhodes Jason P (Director) has filed a Form 4 on Generation Bio Co.
Txns: Granted 25,000 options to buy @ $4.83, valued at $120.8k
05/25/2023 4 Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 16,500 options to buy @ $18.26, valued at $301.3k
10/06/2021 4 Rhodes Jason P (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE
Txns: Granted 17,245 options to buy @ $3.8, valued at $65.5k
09/29/2021 4 Rhodes Jason P (Director) has filed a Form 4 on Generation Bio Co.
Txns: Sold 51,294 shares @ $25.7, valued at $1.3M
Sold 95 shares @ $25.7, valued at $2.4k
Sold 13,089 shares @ $25.24, valued at $330.4k
Sold 24 shares @ $25.24, valued at $605.8
Sold 16,556 shares @ $24.59, valued at $407.1k
Sold 30 shares @ $24.59, valued at $737.7
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2021 4 Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 19,596 options to buy @ $19.56, valued at $383.3k
04/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 3 Rhodes Jason P (Director) has filed a Form 3 on Gemini Therapeutics, Inc. /DE
01/28/2021 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 5,558 shares @ $46.14, valued at $256.4k
12/22/2020 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 3,012 shares @ $41.95, valued at $126.4k
Sold 1,042 shares @ $41.95, valued at $43.7k
Sold 265 shares @ $41.95, valued at $11.1k
12/17/2020 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 28,078 shares @ $42.4, valued at $1.2M
Sold 349 shares @ $43.12, valued at $15k
Sold 70 shares @ $44.08, valued at $3.1k
Sold 9,710 shares @ $42.4, valued at $411.7k
Sold 120 shares @ $43.12, valued at $5.2k
Sold 24 shares @ $44.08, valued at $1.1k
Sold 2,432 shares @ $42.4, valued at $103.1k
Sold 30 shares @ $43.12, valued at $1.3k
Sold 6 shares @ $44.08, valued at $264.5
Sold 8,849 shares @ $42.13, valued at $372.8k
Sold 3,060 shares @ $42.13, valued at $128.9k
12/14/2020 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 12,691 shares @ $42.68, valued at $541.7k
Sold 8,666 shares @ $43.48, valued at $376.8k
Sold 2,653 shares @ $44.35, valued at $117.7k
Sold 4,389 shares @ $42.68, valued at $187.3k
Sold 2,996 shares @ $43.48, valued at $130.3k
Sold 917 shares @ $44.35, valued at $40.7k
Sold 1,099 shares @ $42.68, valued at $46.9k
Sold 750 shares @ $43.48, valued at $32.6k
Sold 230 shares @ $44.35, valued at $10.2k
Sold 19,712 shares @ $43.32, valued at $853.9k
Sold 2,374 shares @ $43.92, valued at $104.3k
12/09/2020 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 8,636 shares @ $45.46, valued at $392.6k
Sold 23,174 shares @ $45.97, valued at $1.1M
Sold 1,222 shares @ $46.91, valued at $57.3k
Sold 2,962 shares @ $45.45, valued at $134.6k
Sold 26,713 shares @ $46.06, valued at $1.2M
Sold 2,322 shares @ $46.93, valued at $109k
Sold 748 shares @ $45.46, valued at $34k
Sold 2,007 shares @ $45.97, valued at $92.3k
Sold 106 shares @ $46.91, valued at $5k
Sold 7,001 shares @ $46.02, valued at $322.2k
Sold 33,133 shares @ $46.94, valued at $1.6M
09/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2020 3 Rhodes Jason P (10% Owner) has filed a Form 3 on Dyne Therapeutics, Inc.
06/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 Rhodes Jason P (Director) has filed a Form 4 on Generation Bio Co.
Txns: Granted 52,000 options to buy @ $19, valued at $988k
06/11/2020 3 Rhodes Jason P (Director) has filed a Form 3 on Generation Bio Co.
04/02/2020 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 16,500 options to buy @ $9.78, valued at $161.4k
11/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2018 4 Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Converted 3,439,839 shares @ $0
Converted 1,013,547 shares @ $0
Converted 3,439,839 convertible preferred @ $0
Converted 1,013,547 convertible preferred @ $0
Granted 13,500 options to buy @ $15, valued at $202.5k
07/19/2018 3 Rhodes Jason P (Director) has filed a Form 3 on Replimune Group, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy